Use of systemic glucocorticoids and risk of breast cancer in a prospective cohort of postmenopausal women

BACKGROUND: Glucocorticoids could theoretically decrease breast cancer risk through their anti-inflammatory effects or increase risk through immunosuppression. However, epidemiological evidence is limited regarding the associations between glucocorticoid use and breast cancer risk. METHODS: We inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Cairat, Manon, Al Rahmoun, Marie, Gunter, Marc J., Heudel, Pierre-Etienne, Severi, Gianluca, Dossus, Laure, Fournier, Agnès
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330083/
https://www.ncbi.nlm.nih.gov/pubmed/34340701
http://dx.doi.org/10.1186/s12916-021-02004-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330083/
https://www.ncbi.nlm.nih.gov/pubmed/34340701
http://dx.doi.org/10.1186/s12916-021-02004-6

Ejemplares similares